Registered Members Login:
   
Forgotten Your Details? Click Here To Recover +
Welcome To The ShareCafe Community - Talk Shares And Take Stock With Smart Investors - New Here? Click To Register >

4608 Pages (Click to Jump) V  « < 304 305 306 307 308 309 310 > »    
 
  
Reply to this topic

CUV, CLINUVEL PHARMACEUTICALS LIMITED
seeva222
post Posted: Feb 8 2019, 12:24 AM
  Quote Post


Posts: 1,322
Thanks: 1378



As exemplified previously, we have seen the need for us to change our infrastructure to be able to compete in years to come, this requires investments in technology and, at opportune times, in further expansion of the Group through acquisitions.

 
MinusSinus
post Posted: Feb 8 2019, 12:00 AM
  Quote Post


Posts: 21
Thanks: 58


In Reply To: NewToCli's post @ Feb 7 2019, 10:53 PM

QUOTE
Clinuvel hired a new IR Manager, Malcom Bull, he joined Cuv in January in Melbourne.


Great name for that role.




--------------------
Comments on Clinuvel on my value investing blog (English):
https://www.minussinus.de/2017/11/14/for-english-readers-of-minussinus/

Said 'Thanks' for this post: NewToCli  royco  rabbitrun  
 
NewToCli
post Posted: Feb 7 2019, 10:53 PM
  Quote Post


Posts: 672
Thanks: 1248


Good news !!!! Clinuvel hired a new IR Manager, Malcom Bull, he joined Cuv in January in Melbourne. He is a well experienced banker and IR Manager..
Look out for him in LinkedIn

Fingers crossed he brings in new transparency and guidance to attract more shareholders!! Clinuvel is preparing for something big!!


Said 'Thanks' for this post: odi01  sharelooker  investek  Johnny H  nickr  Zodiac1  Dr Wally  
 
Farleap11
post Posted: Feb 7 2019, 09:28 PM
  Quote Post


Posts: 107
Thanks: 165


In Reply To: investek's post @ Feb 7 2019, 07:36 PM

I am not sure why but Mr Babul's paper dated 6 February 2019 makes reference to the 2017 NICE decision not to recommend reimbursement for Scenesse as an EPP treatment, and goes on to say that this ruling was upheld in 2018 on appeal.


My understanding of the situation from a Clinuvel Company Announcement on the 10 October 2018 is that CUV's Appeal against the NICE recommendation was upheld and that the matter was to be referred back to the Highly Specialised Technology (HST) Committee for further review.


Whilst revisiting the 10 October announcement, I noted that it went on to point out that - " No further appeal avenue is available under the NICE Appeal Process, however consultees [CUV and 3 other EPP representative bodies], have up to three months to apply to the High Court for judicial review." In addition in a follow up 'Pink Sheet' report dated 12 October 2018, Dr Wolgen is quoted on page 3 as saying that, " Clinuvel's position is to wait but not too long, to see if NICE takes the initiative [to make reasonable adjustments after revisiting their original recommendations],. If not, then our path is still open for applying to the High Court for a judicial Review. In fairness, we could wait a couple of weeks, but certainly not months." He said the company "could apply for a judicial review tomorrow but we should give them a chance to come back to us. we have three months to appeal - I don't think we should wait that long, but I am open to their phone call,"

The next reference I could find to what happened after these October 2018 announcements is contained in the last paragraph of the Philippe Wolgen Communique dated 15 January, which reads in part, " ...Clinuvel is still in process of requesting NICE to respect the EMA's outcome (marketing authorisation: October 2014) and make Scenesse available to British EPP patients. we will keep you informed later this quarter as we expect news from NICE/NHS England around this time. " It seems clear from this that the process is ongoing; however it does beg the question as to whether the three month count down for a High Court for a judicial Review begins from the date of the initial NICE decision or from when the review decision of the NICE/HST Committee is announced? Logically one would think that it should be 3 months from the date of the final decision i.e. after further review. However Wolgen has sowed a seed of doubt in my mind when he says that the company, "could apply for judicial review tomorrow. etc. ..

Can anyone enlighten me please !


And yes Clinhope, I was surprised but pleased with todays closing price on the ASX. I think it is being influenced to the increasing speculation surrounding entry into the ASX 200 (or not).


Said 'Thanks' for this post: investek  
 
NewToCli
post Posted: Feb 7 2019, 08:17 PM
  Quote Post


Posts: 672
Thanks: 1248


In Reply To: investek's post @ Feb 7 2019, 06:51 PM

well, chart analysis is always just a best guess and most people dont give it any credentials. Predicting past prices for future movements can always be only a guess... but once the market startes behaving in those patterns, why not include them in an analysis... I think I once posted a similar chart as below... before the break out. Even the long-term trend has been tested from above and then now the break-out is quite a good and strong signal... (if you click the pic it opens in the right order)
Attached thumbnail(s)
Attached Image


 



Said 'Thanks' for this post: investek  nickr  
 
investek
post Posted: Feb 7 2019, 08:00 PM
  Quote Post


Posts: 225
Thanks: 848


Today’s commentary on CUV from Newing and a photo of Najib Babul for those curious.

QUOTE
Thur 7 Feb - Trading portfolio
The portfolio slipped 0.1% today. Best were CUV +4% and VTG +5%. Worst were SAR -5% and BGL -4%. In the current environment gold stocks are under-performing compared with the banks and iron ore miners.

CUV ($23.45 up $1.00) has broken out! I included the charts in yesterday’s blog so won’t repeat them here, but it does look good.

Attached image(s)
Attached Image

 


 


investek
post Posted: Feb 7 2019, 07:36 PM
  Quote Post


Posts: 225
Thanks: 848


Awareness of CUV seems to be growing in the US...

San Diego Entrepreneurs Exchange (SDEE)
Erythropoietic Protoporphyria: An Unmet Medical Need for a Severe Photodermatosis
Najib Babul posted by NAJIB BABUL | 96
http://www.sdentrepreneurs.org/najibbabul/...photodermatosis

Najib Babul, PharmD, MBA is an accomplished pharmaceutical scientist, drug developer, inventor, and biotech entrepreneur with more than twenty years of experience in bringing new drugs to market
http://najibbabulnews.com

http://twitter.com/intent/user?screen_name=najibbabulrelma


Said 'Thanks' for this post: odi01  Farleap11  Dr Wally  
 
investek
post Posted: Feb 7 2019, 06:51 PM
  Quote Post


Posts: 225
Thanks: 848


In Reply To: NewToCli's post @ Feb 7 2019, 06:21 PM

I’m no chartist or technical trader either however some bloke Graeme Newing seems to agree with you and Waz.

QUOTE
Tue 5 Feb - Trading portfolio
The portfolio rose 0.2% today. By far the best performer was CUV +6% followed by ATU +4%. Worst was BRB -4%.

The CUV price at $22.65 is now right on the downtrend line from the September top of $24.10. If it gets through this then it still has to get through $24.10. After that, the sky is the limit. Well, perhaps not the sky – just $41.50.


http://www.newingonstocks.com

Newing’s chart below.
http://www.newingonstocks.com/wp-content/u.../CUV-190205.png
Attached thumbnail(s)
Attached Image


 



Said 'Thanks' for this post: BS45  waz  odi01  nickr  
 
NewToCli
post Posted: Feb 7 2019, 06:21 PM
  Quote Post


Posts: 672
Thanks: 1248


In Reply To: waz's post @ Feb 7 2019, 05:53 PM

That’s what I posted some time ago.. we are in a new up move after the triangle consolidation with price target above 30 aud


Said 'Thanks' for this post: waz  
 
Frogster
post Posted: Feb 7 2019, 06:18 PM
  Quote Post


Posts: 583
Thanks: 2071


In Reply To: Clinhope's post @ Feb 7 2019, 04:59 PM

Wake me up when it's 123.45. smile.gif



--------------------
Dr Wolgen is a magician.
His end game for Scenesse will impress, or even amaze.
En route, along with glimmers of truth, there will be distractions, illusions, sleight of hand and misdirection.
Enjoy the ride.

Said 'Thanks' for this post: Clinhope  xray  macgyver  waz  Verharven  
 
 


4608 Pages (Click to Jump) V  « < 304 305 306 307 308 309 310 > » 

Back To Top Of Page
Reply to this topic


You agree through the use of ShareCafe, that you understand and accept the TERMS OF USE.


TERMS OF USE  -  CONTACT ADMIN  -  ADVERTISING